venlafaxine hydrochloride
- Product NDC
- 64725-0034
- 11-digit product format
- 647250034
- Labeler code
- 64725
- Product ID
- 64725-0034_a725cf7e-3cda-484d-acaf-28f3ace2dcbc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- venlafaxine hydrochloride
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- TYA Pharmaceuticals
- Application
- ANDA090174
- Marketing category
- ANDA
- Marketing start
- 2011-06-01
- Marketing end
- 0000-00-00
- Substance
- VENLAFAXINE HYDROCHLORIDE
- Active strength
- 38 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 64725-0034-1 | venlafaxine hydrochloride | 30 in 1 CONTAINER | CAPSULE, EXTENDED RELEASE | 30 | | 4 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| VENLAFAXINE HYDROCHLORIDE | ACTIVE INGREDIENT | 7D7RX5A8MO | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
| VENLAFAXINE | ACTIVE MOIETY | GRZ5RCB1QG | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
| CETOSTEARYL ALCOHOL | INACTIVE INGREDIENT | 2DMT128M1S | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
| ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW) | INACTIVE INGREDIENT | P2OM2Q86BI | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 64725-0034 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TYA PHARMACEUTICALS] | 4 | Legacy NDC, 1 package rows | 20141110_01d6c49d-f831-44dc-bd59-dc93ebdeee2f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 64725-0034-1 | 64725003401 | 30 in 1 CONTAINER | Historical |